Following this transaction Timothy Haines’ holding in the company was increased by 6.28% to a total of $645.5K. This is Haines’ first transaction since reporting a Buy transaction on SIEN back in May 2018
Currently, Proteon has an average volume of 760.65K. The company has a one-year high of $3.94 and a one-year low of $0.22.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.